In the first step, we examined the distribution of the genotypes and alleles of the selected polymorphisms of the CDKN1B and CCND2 genes in the CLL patients and control subjects, and we analyzed the relationship between the polymorphisms studied and susceptibility to CLL. This evidence concerns the gene CCND2 and B-cell chronic lymphocytic leukemia.